Roche Holding AG (LTS:0QOK)
CHF 263.05 -1.65 (-0.62%) Market Cap: 211.30 Bil Enterprise Value: 236.93 Bil PE Ratio: 19.78 PB Ratio: 7.21 GF Score: 86/100

Q1 2022 Roche Holding AG Corporate Sales Call Transcript

Apr 25, 2022 / 12:00PM GMT
Release Date Price: CHF361.7 (-2.00%)
Operator

(Operator Instructions)

One last remark, if you would like to follow the presented slides on your end as well, please feel free to go to www.roche.com/investors to download the presentation.

At this time, it's my pleasure to introduce you to Severin Schwan, CEO of Roche Group. Mr. Schwan, the stage is yours.

Severin Schwan
Roche Holding AG - CEO & Executive Director

Thank you very much, and welcome to everybody to our Q1 briefing today. So let's go right into the slides.

Here we go. Yes, overall, a strong start into the year, sales overall up by 11% at constant rates, good growth in both Pharma and Diagnostics. And what I should point out is that this is not only a sign of strong COVID sales, but what we also see is a strong growth of the underlying sales. I'll come back to that in a moment. Actually, the underlying sales on a group level grew by 9%.

The second key element here is the progress we made with our portfolio. So it's really good to see

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot